Skip to main content
SpringerLink
Log in

UMC identifies paediatric safety signals from VigiBase

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. UMC = Uppsala Monitoring Centre

  2. including for levetiracetam (Keppra), desloratadine (Neoclarityn) and deferasirox.

Reference

  • Star K, et al. Paediatric safety signals identified in VigiBase: Methods and results from Uppsala Monitoring Centre. Pharmacoepidemiology and Drug Safety : [10 pages], 15 Feb 2019. Available from: URL: http://dx.doi.org/10.1002/pds.4734

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

UMC identifies paediatric safety signals from VigiBase. Reactions Weekly 1742, 12 (2019). https://doi.org/10.1007/s40278-019-58470-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-019-58470-7

Search

Navigation